Elanco Animal Health (ELAN)
NYSE: ELAN
· Real-Time Price · USD
17.95
-0.05 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
17.96
0.08%
After-hours: Aug 15, 2025, 06:16 PM EDT
Elanco Animal Health Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 11M | 67M | -8M | 364M | -50M | 32M | -141M | -1.1B | -97M | 103M | -55M | -49M | -22M | 48M | -97M | -104M | -210M | -61M |
Depreciation & Amortization | 169M | 161M | 164M | 170M | 162M | 166M | 171M | 173M | 177M | 173M | 168M | 167M | 171M | 176M | 174M | 170M | 170M | 202M |
Stock-Based Compensation | 20M | 15M | 15M | 15M | 14M | 11M | 15M | 10M | 9M | 12M | 15M | 13M | 17M | 14M | 18M | 17M | 16M | 15M |
Other Working Capital | 237M | -237M | 56M | 155M | 22M | -177M | 146M | 27M | -34M | -439M | 275M | -15M | -38M | -331M | 274M | -53M | -7M | -183M |
Other Non-Cash Items | -200M | -10M | -50M | -542M | 52M | -30M | 19M | 37M | 9M | 4M | -16M | 69M | 213M | 42M | 7M | 64M | 262M | 81M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -53M | 1.05B | -3M | 2M | -21M | 4M | -29M | -11M | -35M | -5M | -82M | -32M |
Change in Working Capital | 237M | -237M | 56M | 155M | 22M | -177M | 146M | 27M | -34M | -439M | -78M | -15M | -38M | -331M | 156M | -53M | -7M | -183M |
Operating Cash Flow | 237M | -4M | 177M | 162M | 200M | 2M | 157M | 198M | 61M | -145M | 13M | 189M | 312M | -62M | 223M | 89M | 149M | 22M |
Capital Expenditures | -57M | -65M | -53M | -42M | -34M | -24M | -41M | -33M | -42M | -38M | -79M | -46M | -33M | -26M | -91M | -25M | -25M | -56M |
Cash Acquisitions | -7M | 7M | -36M | 5M | n/a | -5M | n/a | -3M | n/a | -16M | 2M | 11M | n/a | n/a | n/a | -415M | n/a | 73M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 8M | n/a | -7M | 1.28B | 1M | 66M | 6M | n/a | -1M | -1M | 1M | -2M | -4M | -3M | -8M | -1M | -8M | -7M |
Investing Cash Flow | -56M | -58M | -90M | 1.24B | -33M | 37M | -35M | -36M | -43M | -55M | -76M | -37M | -37M | -29M | -74M | -441M | -25M | 10M |
Debt Repayment | -446M | 72M | -38M | -1.33B | -92M | -13M | -139M | -156M | 37M | 181M | -70M | -154M | -89M | -189M | 46M | 232M | -67M | 30M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 290M | -20M | 6M | -8M | -1M | -14M | n/a | -1M | 2M | -7M | -14M | -15M | -7M | -11M | -2M | -1M | n/a | -28M |
Financial Cash Flow | -156M | 52M | -32M | -1.34B | -93M | -27M | -139M | -157M | 39M | 174M | -84M | -169M | -96M | -200M | 44M | 231M | -67M | 2M |
Net Cash Flow | 52M | 19M | -22M | 74M | 71M | -7M | -17M | 2M | 49M | -27M | -115M | -47M | 165M | -296M | 185M | -127M | 65M | 9M |
Free Cash Flow | 180M | -69M | 124M | 120M | 166M | -22M | 116M | 165M | 19M | -183M | -66M | 143M | 279M | -88M | 132M | 64M | 124M | -34M |